The right atrial auricle-Worthy of a new look.

INTRODUCTION: The right atrium is the least well studied cardiac chamber. Even less is known about the right atrial appendage (RAA). Recently, the RAA has been shown to be the site of numerous and diverse pathological processes. Furthermore, the RAA can also be the site of origin of atrial fibrillation with obvious implications for ablation procedures. No standard method of transthoracic echocardiography (TTE) for imaging of the RAA can be found in current literature, despite numerous reports for transesophageal echocardiography (TEE). PURPOSE OF THIS STUDY: The purpose of this study was to determine if a reliable transthoracic window could be found for consistent and reliable imaging of the RAA. METHOD: 30 patients (15 men and 15 women) were included into this study. All patients were placed in the left lateral decubitus position and echocardiography was performed with a Vivid E9 ultrasound system (GE Healthcare). The RAA was visualized by tilting the probe infero-medially from the standard apical four chamber view. RESULTS: The RAA was visualized in all 30 patients. The RAA followed a consistent upwards and leftwards path anterior to the aortic root. CONCLUSION: TTE is a valid method of imaging of the RAA.

Budget Impact Analysis of Empagliflozin in the Treatment of Patients With Type 2 Diabetes With Established Cardiovascular Disease in South Africa.

OBJECTIVES: This study aimed to estimate the budget impact and affordability of empagliflozin added to usual care compared with usual care alone, in a diabetic population with established cardiovascular disease, from a private healthcare payer perspective in South Africa. METHODS: A budget impact model was adapted and localized. Epidemiological data were obtained from the South African Council for Medical Schemes. Clinical event rates were sourced from the EMPA-REG OUTCOME trial and drug costs from list prices. Clinical event costs were derived from a claims data analysis of the South African private healthcare sector and microcosting. Scenario analyses were performed on select inputs. The modeled outcomes included annual budget impact of empagliflozin, the incremental cost per life per month, cardiovascular deaths averted, and incremental cost per life saved, over 3 years. RESULTS: A total of 9 503 patients were eligible for empagliflozin (year 1), 12 670 (year 2), and 16 947 (year 3). The incremental cost was $1 272 297, $1 764 705, and $2 455 235, for years 1 to 3, respectively. The incremental cost per beneficiary per month was calculated as $0.012 (year 1), $0.016 (year 2), and $0.023 (year 3). The model estimated a 38.6% reduction in cardiovascular deaths, 305 lives saved, and an incremental cost per life saved of $17 999. CONCLUSIONS: Adding empagliflozin to usual care has a marginal budget implication and is highly affordable for private healthcare payers, with an acceptable incremental cost based on clinical outcomes.

Pelvic kidney as a cause of May-Thurner syndrome.

Deep venous thrombosis is a common clinical problem with significant morbidity and mortality. Since the iconic publication by Virchow in 1856, which placed all known causes of deep venous thrombosis into three groups, namely venous stasis, vascular injury and hypercoagulability, numerous causes have been added to each category. This case report highlights the importance of an anatomical imaging study of the pelvis in cases of recurring, proximal deep venous thrombosis of the lower limb.

NT-proBNP: When is it useful in Obstetric Medicine?

Pregnancy, viewed as a stress test of the haemodynamic system, may unmask underlying cardiac disease. Pregnancy may also induce de novo cardiac disease. N-terminal pro brain-type natriuretic peptide (NT-proBNP) is a useful biomarker in all clinical conditions in which the ventricle is stressed and especially stretched in the general population. In hypertensive diseases of pregnancy, increased levels of NT-proBNP in preeclampsia are associated with increased cardiac filling pressures and diastolic dysfunction. Increased levels of NT-proBNP in pregnant women with known cardiac disease may lead to earlier diagnosis of impending heart failure. Similarly, elevated levels of NT-proBNP assist with the diagnosis of peripartum cardiomyopathy and are increasingly used in follow-up. Women with known congenital heart disease who are pregnant can be screened for risk of cardiac events such as heart failure by the use of NT-proBNP levels. There is a paucity of data in pregnancy with the use of NT-proBNP and more research is needed.

Rheumatoid arthritis and risk of cardiovascular disease.

In developing countries, rheumatoid arthritis (RA) remains a seriously under-prioritised disease, particularly among the underprivileged, often resulting in presentation of patients late in the course of their disease, further complicated by limited therapeutic options and inconsistent follow up. The consequences are often severe with irreversible disability, increased frequency of co-morbidities, especially cardiovascular disease (CVD), and higher mortality rates, relative to developed countries. Despite addressing traditional cardiovascular risk factors, the impact of subclinical or 'residual' inflammation from uncontrolled RA needs to be considered. This narrative review explores the prevalence and pathogenesis of CVD in RA, including the impact of tobacco use. It discusses pitfalls in the risk assessment of CVD in patients with RA, and the effect of disease-modifying anti-rheumatic therapy on cardiovascular co-morbidity.

Aortic Arch Baroreceptor Stimulation in an Experimental Goat Model: A Novel Method to Lower Blood Pressure.

The effect of aortic baroreceptor stimulation on blood pressure manipulation was assessed using the goat species Capra aegagrus hircus. The aim of this study was to manipulate blood pressure with future intention to treat high blood pressure in humans. The ages of the animals ranged from 6 months to 2 years. A standard anesthesia protocol was used. A lateral thoracotomy was performed to gain access to the aortic arch. Data was collected with the Vigileo system. Pre stimulation blood pressure was compared with maximum post stimulation blood pressure values. Results were analyzed with the Wilcoxon signed rank test. In the study 38 animals were enrolled. Baroreceptor stimulation was performed for each animal using 3 different electrodes each of which emits an electrical impulse. In the pilot phase of the study, the median baseline blood pressure prior to stimulation of the baroreceptors was 110.8 mmHg. After stimulation the median blood pressure decreased to 88 mmHg. The average decrease in blood pressure was 22.8 mmHg. This decrease of blood pressure after stimulation of the baroreceptors is statistically significant (p < 0.0001) and the proof of concept was shown. During the extended phase all three probes had a significant effect on blood pressure lowering (p < 0.0001). The study confirmed that aortic baroreceptor stimulation has an effect on blood pressure lowering. This is a novel field of blood pressure manipulation. The hemodynamic effects of long-term aortic baroreceptor stimulation are unknown. Further investigations need to be done to determine whether a similar effect can be induced in different species such as primates and humans.

Non-acid gastro-oesophageal reflux is associated with squamous cell carcinoma of the oesophagus.

INTRODUCTION: Squamous cell carcinoma of the oesophagus is a common cancer among South Africans. Due to the absence of effective screening and surveillance programme for early detection and late presentation, squamous cell carcinoma of the oesophagus is usually diagnosed at an advanced stage or when metastasis has already occurred. The 5-year survival is often quoted at 5%-10%, which is poor. OBJECTIVES: To determine the association between oesophageal squamous cell carcinoma (OSCC) and non-acid gastro-oesophageal reflux disease. METHODS: Study design: A cross-sectional case-control analytical study of patients referred to the Gastroenterology Division of Steve Biko Academic Hospital in Pretoria, South Africa. All patients had combined multichannel impedance and pH studies done and interpreted after upper gastroscopy using the American College of Gastroenterology guidelines by two clinicians. RESULTS: Thirty-two patients with OSCC were recruited: non-acid reflux was found in 23 patients (73%), acid reflux in 2 patients (6%) and 7 patients (22%) had normal multichannel impedance and pH studies.Forty-nine patients matched by age, gender and race were recruited as a control group. Non-acid reflux was found in 11 patients (22%), acid reflux in 31 patients (63%) and 7 patients (14%) had normal multichannel impedance and pH monitoring study. CONCLUSION: The significance of the association between non-acid reflux and OSCC was tested using χ2, and simple logistic regression was used to adjust for the effects of potential confounders.The OR of developing OSCC in patients with non-acid gastro-oesophageal reflux was 8.8 (95% CI 3.2 to 24.5, P<0.0001) in this South African group.Alcohol and smoking had no effect on these results.

Autonomic impairment in rheumatoid arthritis.

AIM: To determine if there is a difference between autonomic cardiac control as measured by heart rate variability (HRV) in women with rheumatoid arthritis (RA) compared to a healthy control group. METHODS: The RA group (45) and control group (39) were matched for age and body mass index (BMI). Three techniques were used: time domain, frequency domain and Poincarè plot analysis. All possible confounding factors were excluded and the test environment strictly regulated. RESULTS: Basal heart rate was significantly higher in the RA patients. In the supine position significant differences existed between RA patients and controls (P ≤ 0.01). Indicators of parasympathetic activity showed significantly lower variation in the RA group (root mean square of the standard deviation [RMSSD] = 14.70, percentage of successive normal-to-normal interval differences larger than 50 ms [pNN50] = 0.50, standard deviation [SD]1 = 10.50, high frequency [HF] (ms(2)) = 31) compared to controls (RMSSD = 29.40, pNN50 = 7.8, SD1 = 20.9, HF (ms(2)) = 141.00). Indicators of sympathetic variation were also significantly lower in RA patients (SD2 = 36.70, low frequency [LF] (ms(2)) = 65) compared to controls (SD2 = 49.50, LF (ms(2)) = 175). In the standing position eight variables indicated autonomic impairment by significant differences (P ≤ 0.01) between the groups. The response of the RA group to an orthostatic stressor showed less vagal withdrawal, (P-values for RMSSD = 0.038, pNN50 = 0.022, SD1 = 0.043 and HF [ms(2) ] = 0.008 respectively); and lower sympathetic response (P-values for SD2 = 0.001 and LF [ms(2) ] < 0.001) when compared to controls. CONCLUSIONS: An inability of the autonomic nervous system to efficiently compensate for internal and external environmental changes may predispose RA patients to arrhythmias, thereby increasing cardiovascular mortality. All three methods used showed the same outcome, implying decreased HRV and thus an increased risk for arrhythmias in RA patients. Evaluating the autonomic nervous system might be critical in planning management of RA patients.